Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-28

Clinical Trial Update: Keverprazan Combined with Amoxicillin for the Treatment of Helicobacter Pylori [NA]

View source ↗

Summary

A clinical trial evaluating Keverprazan combined with Amoxicillin for Helicobacter pylori infection. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMOXICILLIN (AMOXICILLIN)
  • Keverprazan

Snippet

Sponsor: Key Laboratory for Gastrointestinal Diseases of Gansu Province | Conditions: Helicobacter Pylori | NA | Status: NOT_YET_RECRUITING